InvestSMART

Integrated Research Limited (ASX:IRI)

ALERT: Price-sensitive ASX Announcement for IRI
Current share price for IRI : $0.270 -0.05 (-15.63%)+
Announcement
Release
26 Feb 2026 8:43AM
Price at Release
$0.320
Full Release
download
Summary
Integrated Research Limited reported its FY26 interim results, showing a slight revenue decline of 2% to $28.3 million, attributed to a softer renewals book. Despite a challenging financial environment leading to an EBITDA loss of $3.1 million, the company maintained a strong cash position with an 8% increase to $43.6 million. Key growth initiatives included the launch of new products like 'Iris' and 'Elevate', and a successful implementation of the High Value Payments product with a major US bank. The company emphasized its commitment to a product-led growth strategy and recorded positive progress in new business contributions, with significant new client wins in government, health, and defense sectors. These strategic steps are aimed at enhancing sustainable growth over the medium term.
Key Points
  • Revenue decreased by 2% to $28.3 million compared to the previous corresponding period.
  • EBITDA recorded a loss of $3.1 million due to increased expected credit losses.
  • Cash reserves increased by 8% to $43.6 million.
  • New product launches include 'Iris' for observability and 'Elevate' for cloud-based services.
  • Successful implementation of High Value Payments with a major US bank.
  • Focus on product-led growth strategy and increasing new client revenue.
  • New business revenues saw a contribution of $4.6 million from new client licenses, up 12% from H1 FY25.
  • Government, health, and defense sectors are key client acquisition areas.
  • Continued investment in product innovation is critical for sustainable growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.